Digital Edition

FDA won't take action against pharmacies that compound hydroxyprogesterone caproate

DT Blog

A discussion generated by Drug Topics’ readers, editorial staff, and advisory board Stan Illich, is a former chain store pharmacist, pharmacy owner, army pharmacy officer, vice president/COO of a community health center, and is currently practicing in Mississippi.

"Pharmacy then and now" revisited Read full article.

NCPA, ASCP applaud CMS decision to delay short-cycle dispensing

The Centers for Medicare & Medicaid Services recently decided to delay implementation of its proposed long-term-care "short-cycle dispensing" rule and ease requirements for pharmacists. Read full article.

FDA approves gabapentin enacarbil
for RLS

FDA has approved gabapentin enacarbil (Horizant Extended-Release Tablets, GlaxoSmithKline and XenoPort), a once-daily treatment for moderate-to-severe restless legs syndrome (RLS), also known as Ekbom disease. It is the first medication in its class to be approved for this condition. Read full article.

Combination of ACEI and ARB therapy increases renal risks in elderly

Combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers is associated with increased risk of adverse renal outcomes, according to a recent study published in the Canadian Medical Association Journal. Read full article.

Suppressive therapy manages clopidogrel hypersensitivity

Clopidogrel hypersensitivity, which affects 6% of patients, can be successfully treated using short-course corticosteroids and antihistamines without interrupting drug therapy, reported researchers at Jefferson Medical College in Philadelphia. Read full article.

Rheumatic disease patients may require 2 doses of flu vaccine

Patients with inflammatory rheumatic disease may need 2 doses of adjuvanted split influenza A vaccine to elicit the same antibody response as healthy individuals, reported a recent Swiss study published in Arthritis & Rheumatism. Read full article.

Tiotropium superior to salmeterol
in preventing exacerbations in COPD

The anticholinergic drug tiotropium is more effective than the β2-agonist salmeterol in preventing exacerbations in patients with moderate-to-very-severe chronic obstructive pulmonary disease, according to a multicenter European study published in the New England Journal of Medicine. Read full article.

NACDS urges flexibility on USP container labeling recommendations

NACDS has raised several concerns with the U.S. Pharmacopeia on prescription container labeling.
Read full article.

Meetings and Events

April 16, 2011 Diabetes, Oral Health, & Nutrition: Interrelationships, Innovations, & Interventions
San Francisco, CA
Health professionals not eligible for continuing medical education credit will receive a certificate of participation
that they may submit to their state licensing board for credit.
Contact:
Joslin Diabetes Center
One Joslin Place
Boston, MA 02215
617-732-2400
www.ProfessionalEd.joslin.org

April 27-30, 2011 AMCP's 23rd Annual Meeting & Showcase
Minneapolis, MN
Contact:
100 North Pitt Street Suite 400
Alexandria, VA 22314
800-827-2627; 703-683-8416

April 30-May 3, 2011 NACDS Annual Meeting
Scottsdale, AZ
Contact:
P.O. Box 34814
Alexandria, Virginia 22334-0814
703-837-4300

May 17-19, 2011 ASCP Spring Conference + Exhibition (formerly known as the ASCP Midyear Conference)
Las Vegas, Nevada
Contact:
Alexandria, VA 22314
Phone: 703-739-1300 or 800-355-2727
Fax: 703-739-1321 or 800-220-1321
[email protected]

May 23-25, 2011 NCPA Legislative Conference
Washington, DC
Contact:
100 Daingerfield Road
Alexandria, VA 22314
800-544-7447

Connect to Us

Follow Us on Twitter